Navigation Links
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
Date:11/5/2009

ated symptoms or increased survival with Vectibix. Vectibix has not shown a treatment benefit for patients whose tumors had KRAS mutations in codon 12 or 13.

In December 2007, the EMEA granted a conditional marketing authorization for Vectibix as monotherapy for the treatment of patients with EGFR-expressing mCRC with wild-type KRAS genes after failure of standard chemotherapy regimens. Vectibix has been launched in over 20 countries, Switzerland, Australia and Canada. Applications in the rest of the world are pending.

Important Product Safety Information

Dermatologic Toxicity: Dermatologic toxicities occurred in 89 percent of patients and were severe (NCI-CTC grade 3 and higher) in 12 percent of patients receiving Vectibix monotherapy. Withhold Vectibix for dermatologic toxicities that are grade 3 or higher or are considered intolerable. If toxicity does not improve to </= grade 2 within 1 month, permanently discontinue Vectibix. The clinical manifestations included, but were not limited to, dermatitis acneiform, pruritus, erythema, rash, skin exfoliation, paronychia, dry skin, and skin fissures. Subsequent to the development of severe dermatologic toxicities, infectious complications, including sepsis, septic death, and abscesses requiring incisions and drainage were reported.

Infusion Reactions: Severe infusion reactions occurred in approximately 1 percent of patients. Severe infusion reactions included anaphylactic reactions, bronchospasm, and hypotension. Although not reported with Vectibix, fatal infusion reactions have occurred with other monoclonal antibody products. Stop infusion if a severe infusion reaction occurs. Depending on the severity and/or persistence of the reaction, permanently discontinue Vectibix.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one o
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Call for Applications: The Amgen Award for Science Teaching Excellence
2. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
3. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
4. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
5. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
6. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
7. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
8. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
9. Medarex to Receive Milestone Payment from Amgen
10. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
11. Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015 A new ... cardiovascular monitoring and diagnostic devices market stood at ... reach a value of approximately US$7.0 billion in ... 2013 and 2019. The title of the report ... Holter Monitors, Event Monitors, Cardiovascular Diagnostic Catheters, Implantable ...
(Date:8/31/2015)... 2015  On August 5, 2015, the U.S. District ... denied motions to dismiss securities class action claims ... certain of its directors. The class actions allege that ... scheme to artificially inflate Galena,s stock price, and during ... was inflated, sold massive amounts of their personally-held shares. ...
(Date:8/31/2015)... , Aug. 31, 2015  Regulatory affairs professionals ... where regulations are often strict and legislation is ... a demand for professionals who have a deep ... across a product lifecycle and demonstrate its use ... University of California, Irvine Extension , in partnership ...
Breaking Medicine Technology:Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 4Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 5Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3
... Continuing Progress on Clinical and Preclinical Programs, ... KAL; FWB: CA4), a developer of new drug ... is pleased to provide an,update covering its strategic ... 2007. "Callisto has made substantial progress with ...
... ... with Results due in Q1 ... 2008, ... PPGNY) today,announced the successful completion of a Phase 1b transdermal insulin,trial. The positive ...
Cached Medicine Technology:Callisto Reports on Second-Quarter 2007 Milestones 2Callisto Reports on Second-Quarter 2007 Milestones 3Callisto Reports on Second-Quarter 2007 Milestones 4Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results 2Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results 3
(Date:8/31/2015)... ... August 31, 2015 , ... ... psychology professor Luciana Lagana (aka Dr. Luciana) received a total of three ... Series, Best Documentary, and Best (Dis)ability Film. Dr. Luciana co-wrote and co-produced this ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... selected ezDI’s computer-assisted coding (CAC) software for its Clinical Documentation Improvement (CDI) and ... and a patent pending ICD-10 solution - ezCAC is an enterprise-level coding solution ...
(Date:8/31/2015)... New York (PRWEB) , ... August 31, 2015 , ... ... autumn, when play-offs and the World Series will dominate the sports world. Fans desire ... and eventually advance to the final series. For children, especially those who are too ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... On Saturday, ... A Mission” at the Adams County Fairgrounds in Mendon, IL. The purpose behind this ... districts of Mendon and neighboring town, Quincy. Best Drug Rehabilitation’s sponsorship of “Music with ...
(Date:8/31/2015)... IL (PRWEB) , ... August 31, 2015 , ... In ... studies, Etymotic Research, maker of the BEAN™ personal sound amplifier, is offering caregivers “7 ... sound amplifiers as a way of coping with a variety of home healthcare challenges, ...
Breaking Medicine News(10 mins):Health News:Actor/Writer/Director/Psychology Professor Luciana Lagana Receives Three Wins at the 2015 Global Independent Film Awards for the TV Pilot Dr. Luciana on Aging and Falling 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 3Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 4Health News:New Children's Baseball Series Offers Young Fans a Way to Celebrate the World Series 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3
... Group Will Work to Prevent Sudden Cardiac Arrest Through ... Sudden Cardiac Arrest,Association (SCAA) announced today that it has ... of local organizations to help carry out its,mission of ... chapter is led by Elliot Fisch of Boca Raton, ...
... to Prevent Sudden Cardiac Arrest Through Public,Education and Advocacy, ... Spring, WASHINGTON, Jan. 8 The Sudden Cardiac ... first 13 local,chapter and affiliate organizations, as it builds ... mission of preventing sudden cardiac,arrest., The local chapters ...
... Over-The-Air Transmission From Special CES Station, LAS ... Harris,Corporation and Towson University today announced a new ... of millions of hearing and visually,impaired people around ... the Consumer Electronics Show in Las Vegas,the three ...
... The Department of Labor,s,Occupational Safety and Health Administration ... review of its methylene chloride (MC),Standard (29 CFR ... July 10, 2007, Federal Register (72 FR 37501 ... 1997 to protect employees from occupational,exposure to MC. ...
... Metabolism, a publication of Cell Press, provides new evidence explaining ... muscles up in response to exercise. These findings could lead ... occurs in diseases such as cancer and AIDS as well ... , The researchers showed that a transient and local rise ...
... risk, experts say , , TUESDAY, Jan. 8 (HealthDay News) -- ... risk of having a heart attack, a new study reports. ... of heart problems, this is the first time that chronic ... "There is an independent contribution of anxiety that can predict ...
Cached Medicine News:Health News:Sudden Cardiac Arrest Association Launches South Florida Chapter 2Health News:Sudden Cardiac Arrest Association Launches South Florida Chapter 3Health News:Sudden Cardiac Arrest Association Launches Its First Thirteen Local Chapters/Affiliates 2Health News:Sudden Cardiac Arrest Association Launches Its First Thirteen Local Chapters/Affiliates 3Health News:NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired 2Health News:NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired 3Health News:NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired 4Health News:NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired 5Health News:OSHA Extends Comment Period for Lookback Review of Methylene Chloride Standard 2Health News:New insight into factors that drive muscle-building stem cells 2Health News:Anxiety Raises Heart Attack Risk 2Health News:Anxiety Raises Heart Attack Risk 3
Direct assays, no sample extraction, hydrolysis or other pretreatment required. Highly specific antiserum, minimal cross-reactivity with estrone, estradiol and other estrogen metabolites....
Helmer's Horizon Series line of refrigerators are designed specifically for the cost conscious buyer. This line offers outstanding performance, quality, and the features you need to ensure the safety...
... Helmer presents the ... with innovative solutions for ... more sophisticated features than ... Bank Refrigerators are at ...
... the precise requirements of blood banking ... Bank Equipment meets American Association of ... Cross (ANRC) and U.S. Food & ... freezers, and platelet incubators feature alarm ...
Medicine Products: